Inventor · disambiguated record
Paul Galatsis
Also filed as: GALATSIS PAUL
13 granted patents·3 pending applications·103 citations·filing 1997–2025
89Inventor score
Files withPFIZER6ENKO CHEM INC5TRANSNEURAL THERAPEUTICS INC2WARNER LAMBERT CO2VIBLIOME THERAPEUTICS LLC1
Top patents by PatentIndex Score
16 records- 0192US11889833B2Protoporphyrinogen oxidase inhibitorsENKO CHEM INC·Filed 2023·Granted Feb 6, 2024·2 cites·25 claims
- 0292US5919790AHydroxamate inhibitors of interleukin-1β converting enzymeWARNER LAMBERT CO·Filed 1997·Granted Jul 6, 1999·60 cites·16 claims
- 0390US10039753B2Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitorsPFIZER·Filed 2016·Granted Aug 7, 2018·14 cites·29 claims
- 0487US9642855B2Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitorsPFIZER·Filed 2015·Granted May 9, 2017·6 cites·10 claims
- 0586US9695171B23,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitorsPFIZER·Filed 2014·Granted Jul 4, 2017·10 cites·7 claims
- 0683US9156845B24-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitorsPFIZER·Filed 2013·Granted Oct 13, 2015·6 cites·24 claims
- 0780US11827610B2Protoporphyrinogen oxidase inhibitorsENKO CHEM INC·Filed 2023·Granted Nov 28, 2023·0 cites·25 claims
- 0879US12302900B2Protoporphyrinogen oxidase inhibitorsENKO CHEM INC·Filed 2023·Granted May 20, 2025·0 cites·37 claims
- 0975US2023382876A1Protoporphyrinogen oxidase inhibitorsENKO CHEM INC·Filed 2023·Application pending·0 cites
- 1073US11161844B2Cyclic substituted imidazo[4,5-c]quinoline derivativesPFIZER·Filed 2018·Granted Nov 2, 2021·1 cites·18 claims
- 1164US12459944B2Fused heterocycles as 5-HT2A receptor agonistsTRANSNEURAL THERAPEUTICS INC·Filed 2023·Granted Nov 4, 2025·0 cites·21 claims
- 1264US6875765B2Arylsulfonamide ethers, and methods of use thereofWARNER LAMBERT CO·Filed 2002·Granted Apr 5, 2005·4 cites·29 claims
- 1359US2025084044A1Protoporphyrinogen oxidase inhibitorsENKO CHEM INC·Filed 2023·Application pending·0 cites
- 1455US12486268B2Fused heterocycles as 5-HT2A receptor agonistsTRANSNEURAL THERAPEUTICS INC·Filed 2025·Granted Dec 2, 2025·0 cites·29 claims
- 1548US11312713B2Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitorsPFIZER·Filed 2018·Granted Apr 26, 2022·0 cites·18 claims
- 1645US2024400577A1Modulators of protein kinasesVIBLIOME THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Galatsis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →